MELBOURNE, Australia: After researching the development of a vaccine for chronic periodontitis for the past 15 years, a team of scientists from the Oral Health CRC at the University of Melbourne has published their latest findings. The results thus far show promising prospects that the vaccine may reduce the need for surgery and antibiotics for patients with severe periodontal disease. According to the researchers, clinical trials could potentially begin on periodontitis patients in 2018.
“Periodontitis is widespread and destructive. We hold high hopes for this vaccine to improve the quality of life of millions of people,” said Prof. Eric Reynolds, CEO of the Oral Health CRC. Developed in collaboration with Australian biopharmaceutical company CSL Limited, the vaccine targets enzymes produced by the bacterium Porphyromonas gingivalis, one of the main periodontal pathogens, triggering an immune response. According to the researchers, this response produces antibodies that neutralise the pathogen’s destructive toxins.
Currently, periodontitis is treated by manually removing toxic plaque that builds up between the tooth and the gingivae, which sometimes involves surgery and antibiotic regimes. Although these measures are helpful, in many cases the bacterium re-establishes itself in the dental plaque, which causes a microbiological imbalance, so the disease continues, Reynolds said.
Epidemiological surveys indicate that moderate to severe forms of periodontitis affect about one in three adults worldwide. Left untreated, the condition can result in the destruction of gingival tissue and ultimately in tooth loss.
Several studies have further linked the disease to an increased risk of various health conditions, including cardiovascular diseases, certain cancers, preterm birth and dementia. If implemented in clinical practise, an effective vaccine for chronic periodontitis could therefore help combat the global burden of these widespread diseases as well.
The results of the study were published in the NPJ Vaccines journal on 1 December in an article, titled “A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis”.
ANAHEIM, Calif., U.S./GUANGZHOU, China: Treatment of periodontitis significantly lowered blood pressure among Chinese patients at risk of developing high ...
BALTIMORE, U.S.: Researchers have recently developed an experimental vaccine that protects up to 80% of mice against Staphylococcus aureus, a Gram-positive ...
A 48-year-old female patient was referred to our clinic owing to a defective amalgam restoration on tooth #46. She had spontaneous acute pain in the area of...
DUMFRIES, Scotland: After years of governmental neglect, the UK is now in the middle of a public dental health crisis. Caused mainly by underfunding and ...
WUHAN, China: Researchers from the Wuhan Institute of Virology at the Chinese Academy of Sciences have created a fusion protein (formed through the joining ...
LOWELL, Mass., U.S.: Crushed or pulverized eggshells have many practical uses. They can be used as a natural calcium supplement, a coffee sweetener, a ...
LIMA, Peru: In a recent study, researchers have developed an integrated intervention programme to reduce the prevalence and severity of early childhood ...
SEOUL, South Korea: The most common cause of peri-implantitis is the formation of a biofilm on the implant surface. Thus, effectively decontaminating the ...
BRUSSELS, Belgium: In 2018, the European Federation of Periodontology (EFP) released a new global classification system for periodontal health, diseases and...
MINNEAPOLIS, U.S.: Scientists have frequently linked some forms of periodontal disease with other inflammatory diseases, and now a new study has suggested ...
The last two years have certainly been challenging times, and many of us have been understandably worried about what it all means for the future of our ...
Live webinar
Wed. 26 March 2025
5:00 am EST (New York)
Live webinar
Wed. 26 March 2025
12:00 pm EST (New York)
Dr. Brent Bankhead DDS, MS, Dr. Talha Mubeen BDS, MOrth RCS Ed., MSc, PhD
Live webinar
Wed. 26 March 2025
3:30 pm EST (New York)
Live webinar
Thu. 27 March 2025
3:00 pm EST (New York)
Live webinar
Fri. 28 March 2025
8:00 am EST (New York)
Dr. Shiu-Fong Ou, Dr. ChingYao Hsieh, Dr. Chien-Ju Lin
Live webinar
Tue. 1 April 2025
12:00 pm EST (New York)
Live webinar
Wed. 2 April 2025
11:00 am EST (New York)
To post a reply please login or register